211
ted Kingdom teenagers: case-control stu-
dy. J Allergy Clin Immunol. 2007;120:381-7.
Meltzer E, Ratner P, Bachert C, Carr W, Ber-
ger W, Canonica GW et al. Clinically rele-
vant effect of a new intranasal therapy
(MP29-02) in allergic rhinitis assessed by
responder analysis. Int Arch Allergy Immu-
nol. 2013;161:369-77.
CarrW, Bernstein J, Lieberman P, Meltzer E,
Bachert C, Price Det al. A novel intranasal
therapy of azelastine with fluticasone for
the treatment of allergic rhinitis. J Allergy
Clin Immunol. 2012;129:1282-1289.e10.
Derendorf H, Meltzer EO, Hermann R, Cano-
nica GW. Clinical development of an advan-
ced intranasal delivery system of azelastine
hydrochloride and fluticasone propionate.
DrugsToday (Barc). 2014;50:15-31.
Simposium
